Tests in

EGFR FISH

  • Test Code:
    8180
  • Department:
    Cancer FISH
  • Test Synonyms:
    EGFR FISH
View Test

Engraftment (Chimerism) Analysis for Allogeneic Hematopoietic Stem Cell

  • Test Code:
    4380 (Donor Pre-Transplant) 4382 (Recipient Pre-Transplant) 4388 (Post-Transplant Chimerism) 4390 (Post-Transplant Sorted Cell Chimerism)
  • Department:
    Hematological Malignancies
  • Test Synonyms:
    Pretransplant DNA storage • Post-transplant DNA for engraftment study • DNA from sorted cells for chimerism study
View Test

Epilepsy/Seizures panel

  • Test Code:
    1291
  • Department:
    Molecular Genetics
  • Test Synonyms:
    Infantile Epilepsy • Childhood Epilepsy • ABAT • ADSL • ALDH5A1 • ALDH7A1 • AMT • ARHGEF9 • ARX • ASPM • ATP1A2 • BTD • CACNA1A • CACNB4 • CASK • CASR • CDKL5 • CHRNA2 • CHRNA4 • CHRNB2 • CLN3 • CLN5 • CLN6 • CLN8 • CNTNAP2 • CPA6 • CSTB • CTSD • DCX • DNAJC5 • EFHC1 • EPM2A • FLNA • FOLR1 • FOXG1 • GABRA1 • GABRG2 • GAMT • GATM • GCH1 • GLDC • GOSR2 • GPR56 • GPR98 • GRIN2A • KCNJ10 • KCNMA1 • KCNQ2 • KCNQ3 • KCTD7 • LGI1 • LIAS • MAGI2 • MBD5 • MCPH1 • MECP2 • MEF2C • MFSD8 • MMACHC • MTHFR • NHLRC1 • NRXN1 • OPHN1 • PAFAH1B1 • PCBD1 • PHGDH • PLCB1 • PNKP • PNPO • POLG • PPT1 • PRICKLE1 • PRICKLE2 • PRRT2 • PSPH • PTS • QDPR • SCARB2 • SCN1A • SCN1B • SCN2A • SCN8A • SCN9A • SLC19A3 • SLC25A22 • SLC2A1 • SLC6A8 • SLC9A6 • SPTAN1 • STXBP1 • SYN1 • TBC1D24 • TCF4 • TPP1 • TSC1 • TSC2 • TSEN54 • UBE3A • WDR45 • WDR62 • ZEB2
View Test

Erythrocytosis Panel

View Test

Exon-Centric Deletion/Duplication Anaylsis

  • Test Code:
    1340
  • Department:
    Molecular Genetics
  • Test Synonyms:
    Exon-centric microarray • Cardiomyopathy • Hypertrophic Cardiomyopathy • Dilated Cardiomyopathy • Noonan Syndrome • Hearing Loss • Autism • Inherited Cancer
View Test

Exon-Centric Microarray to Accompany NGS Panels

  • Test Code:
    1340
  • Department:
    Molecular Genetics
  • Test Synonyms:
    Exon-centric microarray • Cardiomyopathy • Hypertrophic Cardiomyopathy • Dilated Cardiomyopathy • Noonan Syndrome • Hearing Loss • Autism • Inherited Cancer
View Test

EZH2 Mutation Testing

View Test
Innovations in Testing
View All Tests

The Knight Cancer Institute at Oregon Health & Science University is a pioneer in the field of precision cancer medicine. The institute's director, Brian Druker, M.D., helped prove it was possible to shut down just the cells that enable cancer to grow. This breakthrough has made once-fatal forms of the disease manageable and transformed how cancer is treated. The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Cancer Center between Sacramento and Seattle – an honor earned only by the nation's top cancer centers. It is headquarters for one of the National Cancer Institute's largest research collaboratives, SWOG, in addition to offering the latest treatments and technologies as well as hundreds of research studies and clinical trials.

Learn More